Successful Use of a Highly Purified Plasma von Willebrand Factor Concentrate Containing Little FVIII for the Long-Term Prophylaxis of Severe (Type 3) von Willebrand's Disease

被引：18
|
作者：
Simurda, Tomas [1 ]
Dobrotova, Miroslava [1 ]
Skornova, Ingrid [1 ]
Sokol, Juraj [1 ]
Kubisz, Peter [1 ]
Stasko, Jan [1 ]
机构：
[1] Comenius Univ, Jessenius Fac Med Martin, Dept Hematol & Transfusiol, Nat Ctr Hemostasis & Thrombosis, Martin, Slovakia
来源：
SEMINARS IN THROMBOSIS AND HEMOSTASIS | 2017年 / 43卷 / 06期
关键词：
THERAPY; PRINCIPLES; MANAGEMENT; DISORDERS; DIAGNOSIS;
D O I：
10.1055/s-0037-1603362
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：639 / 641
页数：3
相关论文
共 50 条
  • [1] SUCCESSFUL USE OF VON WILLEBRAND FACTOR WITH A LOW FVIII CONTENT FOR THE SECONDARY LONG-TERM PROPHYLAXIS OF VON WILLEBRAND DISEASE TYPE 3-OUR 7 YEARS OF EXPERIENCE
    Simurda, T.
    Skornova, I.
    Drotarova, M.
    Lisa, L.
    Brunclikova, M.
    Stasko, J.
    [J]. HAEMOPHILIA, 2023, 29 : 152 - 152
  • [2] Outcomes of long-term von Willebrand factor prophylaxis use in von Willebrand disease: A systematic literature review
    El Alayli, Abdallah
    Petersen, Romina Brignardello
    Husainat, Nedaa M.
    Kalot, Mohamad A.
    Aljabiri, Yazan
    Turkmani, Hani
    Britt, Alec
    El-Khechen, Hussein
    Shahid, Shaneela
    Roller, John
    Motaghi, Shahrzad
    Mansour, Razan
    Tosetto, Alberto
    Abdul-Kadir, Rezan
    Laffan, Michael
    Weyand, Angela
    Leebeek, Frank W. G.
    Arapshian, Alice
    Kouides, Peter
    James, Paula
    Connell, Nathan T.
    Flood, Veronica H.
    Mustafa, Reem A.
    [J]. HAEMOPHILIA, 2022, 28 (03) : 373 - 387
  • [3] Cost model of long-term prophylaxis with von Willebrand factor concentrate
    Palomero, A.
    Calvo, J. M.
    [J]. HAEMOPHILIA, 2024, 30 : 132 - 133
  • [4] Cost-Effectiveness of Long-Term Prophylaxis Versus on-Demand Treatment with Von Willebrand Factor Concentrate in Severe Inherited Von Willebrand Disease
    Bhaskar, Anushka
    Connell, Nathan T.
    [J]. BLOOD, 2020, 136
  • [5] Long-term prophylaxis in von Willebrand disease
    Berntorp, E
    Petrini, P
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2005, 16 : S23 - S26
  • [6] Cost-Effectiveness of Long-Term Prophylaxis with Plasma-Derived Vs. Recombinant Von Willebrand Factor in Severe Von Willebrand Disease
    Waldron, Christina
    Ito, Satoko
    Wang, Daniel
    Allen, Cecily
    Viswanathan, Giri
    Bona, Robert D.
    Cuker, Adam
    Goshua, George
    [J]. BLOOD, 2023, 142
  • [7] Plasma-derived, purified, pasteurised von Willebrand factor/factor VIII concentrate in the treatment of patients with von Willebrand disease and haemophilia a: update of a long-term observational study
    Wermes, C.
    Holzhauer, S.
    Halimeh, S.
    Kemkes-Matthes, B.
    Sommerer, P.
    Wieland, I
    Krause, M.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 497 - 497
  • [8] CLINICAL STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF A VON WILLEBRAND FACTOR FVIII CONCENTRATE (VWF/FVIII) DURING PROPHYLAXIS IN PREVIOUSLY TREATED PATIENTS WITH VON WILLEBRAND DISEASE (VWD)
    Sidonio, R.
    Dubey, L.
    Timofeeva, M.
    Vilchevska, K.
    Vdovin, V.
    Schmid, M.
    Solomon, C.
    Knaub, S.
    [J]. HAEMOPHILIA, 2020, 26 : 140 - 140
  • [9] PROPHYLAXIS WITH RECOMBINANT VON WILLEBRAND FACTOR IN PATIENTS WITH SEVERE VON WILLEBRAND DISEASE: PHASE 3 TRIAL RESULTS
    Leebeek, Frank W. G.
    Peyvandi, Flora
    Escobar, Miguel
    Tiede, Andreas
    Castaman, Giancarlo
    Gu, Joan
    Mellgard, Bjorn
    Ewenstein, Bruce
    Ozen, Gulden
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : E62 - E63
  • [10] Recombinant von Willebrand factor prophylaxis in patients with severe von Willebrand disease: phase 3 study results
    Leebeek, Frank W. G.
    Peyvandi, Flora
    Escobar, Miguel
    Tiede, Andreas
    Castaman, Giancarlo
    Wang, Michael
    Wynn, Tung
    Baptista, Jovanna
    Wang, Yi
    Zhang, Jingmei
    Mellgard, Bjorn
    Ozen, Gulden
    [J]. BLOOD, 2022, 140 (02) : 89 - 98
12345